Why Pharma and Medical Device Companies Need Modeling & Simulation

Today’s pharmaceutical and medical device companies are facing rising pressure from healthcare communities with patients needing more personalized care, consumers and policy makers pushing to lower healthcare costs, the drive to reduce time and costs to bring new products to market, and complying with increasingly onerous regulations. Meanwhile, the industry is focused on developing more innovative products that improve patient outcomes while decreasing healthcare costs. How does a pharmaceutical or medical device company even begin to try and achieve all these objectives?

Innovating while simultaneously reducing the time and cost of bringing products to market are critical to the financial stability and growth of life science companies. And achieving these goals, without sacrificing quality and patient safety is a prerequisite that is extremely hard to satisfy. Today, in silico (computer-based) methods allow multidisciplinary design teams to perform a large number of simulations to test a variety of designs and therapeutics under various conditions prior to costly and time-consuming physical prototype builds and lab testing that would otherwise not be possible with animal studies and human clinical trials.

Join us for our webinar as we demonstrate the power of modeling and simulation for pharma and medical device companies, and why it’s so important in today’s Life Sciences industry.

Speaker

Karl D’Souza, Life Sciences Industry Solution Experience Director, Dassault Systèmes

Karl D’Souza is a computational modeling and simulation professional with extensive experience in technology consulting, product management, and business development as they pertain to simulation-based solutions for science and technology companies. In his current role as Life Sciences Industry Solution Experience Director at Dassault Systemes, he is responsible for managing the Design and Engineering portfolio of Dassault Systemes’ solutions for medical devices, bio-pharmaceuticals, and patient care. Prior to his current role, he helped grow Dassault Systemes’ Virtual Human Modeling initiative with special focus on cardiovascular and neurological applications, and was a founding member of the Living Heart Project and product manager of the Living Heart Human Model. Karl has a B. Tech in Materials Science and Engineering from IIT Bombay, a MS in Mechanical Engineering from SUNY Buffalo, and an MBA from Bryant University, and is based in Providence, RI, USA. Feel free to reach out to Karl by sending him an email at [email protected].

Message Presenter